Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies.

Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Abstract Text:

    carlos vaccaroCarlos Vaccaro,roger bawdonRoger Bawdon,sylvia wanjieSylvia Wanjie,raimund j oberRaimund J Ober,e sally wardE Sally Ward,

    The MHC class I-related receptor, neonatal Fc receptor (FcRn), plays a central role in regulating the transport and in vivo persistence of immunoglobulin G (IgG). IgG-FcRn interactions can be targeted for engineering to modulate the in vivo longevity and transport of an antibody, and this has implications for the successful application of therapeutic IgGs. Although mice are widely used to preclinically test antibodies, human and mouse FcRn have significant differences in binding specificity. Here we show that an engineered human IgG1 has disparate properties in murine and human systems. The mutant shows improved transport relative to wild-type human IgG1 in assays of human FcRn function but has short in vivo persistence and competitively inhibits FcRn activity in mice. These studies indicate potential limitations of using mice as preclinical models for the analysis of engineered antibodies. Alternative assays are proposed that serve as indicators of the properties of IgGs in humans.

    Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Publishing Authors By Initials

    c vaccaroC Vaccaro,r bawdonR Bawdon,s wanjieS Wanjie,rj oberRJ Ober,es wardES Ward,

    For similar proteins: membrane proteins: receptors, cell surface: receptors, immunologic: receptors, fc research abstracts see: proteins: membrane proteins: receptors, cell surface: receptors, immunologic: receptors, fc research

    PUBMED ID PMID:

    MEDLINE DATE:

    Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Proceedings of the National Academy of Sciences of

    VOLUME: 103

    Page Numbers: 18709-14

    Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

    ISSN: 0027-8424

    DAY: 20

    MONTH: 11

    YEAR: 2006

    Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7505876

    Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Keywords Mesh Terms:

    KEYWORDS: Receptors, Fc

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Information

    Substance Name: Receptors, Fc

    Registry Number: 0

    Grant and Affiliation Information for Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies.

    AFFILIATION: Center for Immunology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-9093, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: R01 AI 55556

    ACRONYM: AI

    MEDLINETA: Proc Natl Acad Sci U S A

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News